CHO Pharma
6586.TWO
1.56 USD
-0.01
-0.64%
c
Overview
Last close
1.56 usd
Market cap
332.23M usd
52 week high
2.66 usd
52 week low
1.53 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
10067.616
Price/Book Value
3.8243
Enterprise Value
260.64M usd
EV/Revenue
7898.7536
EV/EBITDA
-34.5511
Key financials
Revenue TTM
32997.87 usd
Gross Profit TTM
16712.41 usd
EBITDA TTM
-6.62M usd
Earnings per Share
-0.04 usd
Dividend
N/A usd
Total assets
92.60M usd
Net debt
-2.95M usd
About
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
- Symbol6586.TWO
- ExchangeTWO
- IsinN/A
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Chung-Yi Wu Ph.D.
- HeadquarterTaipei
- Web sitehttps://www.chopharma.com
